Introduction: Colorectal cancer (CRC) incidence and mortality rates have decreased dramatically since 1990, both nationally and in California, except among Hispanic men. This study examined trends in CRC incidence, mortality, and survival to determine likely contributing factors for the differential trends between Hispanic and non-Hispanic white men in California.
Introduction
C olorectal cancer (CRC) is the third most common cancer in the U.S., affecting men and women equally. Consistent with national trends, CRC mortality rates have declined substantially in California since the mid-1970s. 1 Between 1990 and 2013, California age-adjusted CRC mortality decreased from 26.9 to 15.2 deaths per 100,000 for men, and from 18.5 to 11.3 deaths per 100,000 for women. 2 Marked declines were reported for men and women in all four major racial/ethnic groups in California except Hispanic men. Although CRC mortality declined among Hispanic women, particularly since 2005, mortality rates among Hispanic men have remained essentially unchanged since 1990. 3 Historically, Hispanic men have had lower rates of CRC mortality compared with non-Hispanic men; however, mortality rates in the two groups are now similar and may soon cross over.
Several reasons may explain differences in CRC rates between non-Hispanic white (white) and Hispanic men. Routine screening for CRC has greatly increased since the 1980s, and has been largely credited for the reduction in CRC incidence. 4 However, Hispanics are less likely to be screened, [5] [6] [7] less likely to be insured, 8 and possibly less likely to utilize health care than other ethnic groups. 9, 10 According to state cancer profiles, 11 the percentage of Hispanic men compliant with CRC screening recommendations in 2014 was 46.2% in the U.S. and 44.9% in California. Among white men, these percentages were much higher: 67.6% and 72.4%, respectively, in the U.S. and California. The U.S. Census Bureau estimates Hispanics now comprise 38.4% of California's population, a percentage essentially identical to whites (39.0%). 12 Exploring reasons for differences in CRC mortality between white and Hispanic men may identify opportunities for improving California's population health.
This study sought to compare trends in CRC incidence, mortality, and survival between Hispanic and white men in California. Trends by age, stage at diagnosis, and location of tumors were examined to assess whether screening and access to health care might explain different CRC trends between Hispanic and white men.
Methods

Study Population
Incidence and survival analyses were based on data routinely collected by the California Cancer Registry on all individuals diagnosed with invasive CRC between January 1, 1990 and December 31, 2012. The registry collects data on cancer patient demographics, diagnosis, tumor characteristics, treatment, and followup. Data are collected through three Surveillance, Epidemiology, and End Results Program (SEER)Àaffiliated regional cancer registries in California, which together cover the entire state. Mortality data were obtained from the California Department of Public Health's Center for Health Statistics Death Master Files, based on ICD-9/ICD-10 codes recorded as the underlying cause of death between January 1, 1990 and December 31, 2013 (2013 data were available for mortality but not for cancer incidence at the time of this analysis). Data used in the study were extracted and analyzed in November 2015.
In this study, CRC was defined according to ICD-Oncology, 3rd edition codes for tumor site (C180-C189, C199, C209, and C260), excluding histology codes 9050-9055, 9140, and 9590-9992 and non-microscopically confirmed cases. Hispanic ethnicity was assigned using the North American Association of Central Cancer Registries' Hispanic and Asian/Pacific Islander Identification Algorithm. 13 This algorithm classifies case patients as Hispanic based on race, birthplace, last name, and maiden name. Hispanic ethnicity may be assigned to individuals of any race, but only nonHispanic whites are classified as white. Age at diagnosis was categorized as o50, 50-64, 65-75, and 475 years. These age groups were chosen to reflect screening recommendations, eligibility for Medicare, and effects of aging on CRC. Tumor subsite was classified as either distal colon and rectum (C185, C186, C187, C199, and C209) or proximal colon (C180, C181, C182, C183, and C184). Previous studies have shown distal colon cancer to be more sensitive to screening, 4 so differences in tumor location may reflect differences in screening. 
Statistical Analysis
Differences in proportions for all study variables were evaluated using R, version 3. 15 Estimates were obtained stratified by race/ethnicity, stage, and age at diagnosis. Patient's vital status was based on the follow-up date of last contact (or death).
Results
Between 1990 and 2012, a total of 23,157 (16.8%) Hispanic and 114,944 (83.2%) white men were diagnosed with CRC in California. Hispanic men tended to be younger, more likely to have Medicaid or other publicly funded health insurance, and more likely to have a tumor located in the distal colon (Table 1) . Hispanic men were also more likely to live in neighborhoods characterized by low SES and lower levels of educational attainment (Table 1) .
Overall, CRC age-adjusted incidence rates in the study period were higher among white men than Hispanic men ( Figure 1) ; however, the two groups exhibited very different incidence trends. Incidence among white men declined from 71. 5 Table 3 ). CRC incidence increased with age in both groups. Men aged o50 years had the lowest incidence rate (5.3 per 100,000), and men aged Z75 years had the highest (383.6 per 100,000, data not shown). Incidence for men aged o50 years increased significantly between 1990 and 2012 for both Hispanics and whites (APC¼2.5 and 1.9, respectively) ( Table 3) . Among white men, incidence in each group of those aged 450 years decreased. For Hispanics, however, CRC incidence increased among men aged 50-64 years (APC¼0.5, p¼0.018) and decreased only after age 65 years, at a slower rate than that among white men of the same age ( Table 3) .
The distribution of tumor location by subsite differed between the two groups: The proportion of tumors in the distal colon and rectum was higher among Hispanic men, whereas the proportion of proximal colon tumors was higher in white men (Table 1) . Incidence rates for both the proximal and distal colon declined substantially for whites, especially near the end of the examined period. Among Hispanics, incidence of distal colon tumors decreased at a slower rate than among whites, but rates for proximal colon CRC did not change (Table 3) .
White men tended to be diagnosed at an earlier stage than Hispanics: 25% of tumors were diagnosed at Stage I among white men, versus 22% for Hispanics (po0.001) ( Table 1) . Changes in CRC stage percentage distribution over time were noticed among both white and Hispanic men, with an increase in Stage I and a decline in Stage II disease (Appendix Figure 1 , available online). The direction and magnitude of changes in percentage distribution were similar in both groups of men. However, although the distribution of tumors by stage for white and Hispanic men remained similar over time, trends in age-adjusted incidence rates by stage differed between the two groups. Incidence rates among white men declined for each individual stage, with the largest decrease observed among stage II tumors diagnosed after 2000 (APC¼À3.8, po0.001) ( Table 3) . Incidence of stage II tumors also declined for Hispanic men (APC¼À1.9, po0.001), but there was little change in the incidence of tumors diagnosed at stage I (APC¼0.6, p¼0.16), stage III (APC¼−0.1, p¼0.80), and stage IV (APC¼0.3, p¼0.38).
Much like incidence, the CRC mortality rate among men in 1990 was higher among whites than Hispanics (Table 2 ) (28.3 per 100,000 vs 18.8 per 100,000), but decreased substantially through 2013 among whites while remaining flat for Hispanics (Table 3) . Among men aged o50 years, CRC mortality rates increased for Hispanics (APC¼1.6, po0.001), but showed no statistically significant change for whites. Mortality rates for white men aged 450 years declined significantly, whereas among Hispanics a decline was detected only in men aged 65-74 years, and at a lower rate than for white men of the same age.
Five-year relative survival for CRC increased significantly in both groups, from 60.4% in 1994-1996 (95% CI¼59. 4 (Figure 2 ). However, as 95% CIs for each time period and within each stage at diagnosis overlapped, none of the differences in 5-year survival between white and Hispanic men were statistically significant (data not shown).
Discussion
Trends in CRC mortality differed greatly between white and Hispanic men in California between 1990 and 2013, declining by 46% among white men but only minimally among Hispanic men. Although mortality was initially higher among white men, by 2011, mortality rates crossed over and were actually higher among Hispanic men. Possible reasons for decreased mortality include increased survival (due to earlier detection or improved treatments) and decreased incidence rates. These findings suggest the difference in mortality trends may be primarily due to changes in incidence. CRC incidence among white men decreased significantly over the study period, whereas incidence among Hispanic men remained flat until 2008, declining afterward. Higher screening rates among whites than Hispanics may have resulted in greater removal of polyps that could have eventually become malignant, thus contributing to lower CRC incidence rates. Five-year relative survival estimates by year of diagnosis were not significantly better among white men. Consistent with previous studies, this study found an increase in relative survival for both white and Hispanic men (Figure 2) . 1, 16 Improvements in relative survival within each American Joint Committee on Cancer stage at diagnosis were similar for both groups. Therefore, differences in survival between white and Hispanic men cannot explain the observed differences in mortality trends.
Lower mortality may also be caused by shifts in the stage at which cancer is diagnosed. Even when survival within each stage remains constant, a larger proportion of patients diagnosed at an earlier stage of disease may lead to overall decreases in mortality. Previous research has shown there may be an overall shift toward earlierstage CRC due to increased screening. 17 However, this study did not show a substantial shift in stage over time. Only a slight decrease in the proportion of tumors diagnosed at stage II and a slight increase in the proportion diagnosed at stage I, III, or IV were observed (Appendix Figure 1, available online) . Changes in stage distribution were similar in both whites and Hispanics; therefore, shifts in the stage at diagnosis are also unlikely to explain differences in mortality trends between the two groups.
As the difference in mortality trends cannot be readily explained by improved survival or shifts in stage at diagnosis, it is likely changes in mortality were mostly driven by trends in incidence. This hypothesis is supported by observed declines in CRC incidence rates since 1990. Rates among Hispanics did not decline until 2008 (Table 3) .
Trends by age group also support the hypothesis that trends in incidence were driven mostly by differential screening. Guidelines do not recommend screening before age 50 years, and incidence rates between 1990 and 2012 increased for both whites and Hispanics aged o50 years (although incidence rates for this age group are much lower compared with older age groups). However, from age 50 to 64 years, white men saw a large decrease in incidence and mortality, whereas Hispanic men saw no significant change in mortality and only a small, statistically significant change in incidence. Both Hispanic and white men aged 65-74 years, when Medicare coverage begins, experienced decreases in incidence and mortality, although the decline was much greater among white men.
Location of the tumor within the colon and rectum may be partly explained by differential screening. Endoscopy is more sensitive to tumors in the distal colon than the proximal colon, and is more likely to reduce incidence and mortality of tumors in the distal colon. 18 This study found Hispanic men more likely to have distal tumors than white men, and the incidence of distal tumors decreased less among Hispanics than whites. Both of these findings are consistent with lower screening rates among Hispanic men.
Several reasons may explain why incidence and mortality declined more rapidly for whites than Hispanics. Most of the decline in CRC incidence has been attributed to increased rates of screening through colonoscopy and sigmoidoscopy, although changes in risk factors and better treatments likely contributed to the decline. 1, 4, 19 These types of screening, which include the removal of adenomatous polyps, have been shown to reduce both CRC incidence and mortality. 19 Despite evidence of its effectiveness, Hispanic men are less likely than white men to undergo endoscopic screening, and Hispanic men in California are no exception. [20] [21] [22] Data from the California Health Interview Survey show lower screening compliance among recent immigrants (48%) and respondents who speak limited English (44%). Differences in CRC screening between Hispanic and non-Hispanic Californian men have been well documented. [22] [23] [24] [25] CRC screening rates among Mexican and South and Central American Hispanic men, the main Hispanic subgroups in California, are the lowest of any race/ethnic group in the country (39% and 35%, respectively). 26 Cultural values and access to health care may explain lower rates of cancer screening among Hispanics in California. Hispanic men are more likely to be uninsured or have Medicaid health insurance, and are less likely to have a primary care provider, all of which decrease the likelihood of CRC screening. 24, 27 Limited language proficiency may be an additional barrier. Hispanics who speak English well are more likely to undergo screening than those with limited English proficiency-a finding even more pronounced among Hispanic men than Hispanic women. 21, 28 Several intervention strategies may be effective in increasing knowledge and uptake of screening guidelines. Two recent reviews described successful intervention strategies for Hispanic CRC screening, 29, 30 including the use of bilingual navigators who are members of the targeted community, educational interventions aimed at providers, and culturally sensitive printed materials. 30, 31 However, even identifying unscreened individuals may be difficult because Hispanics are less likely to have a regular source of medical care. 27, 31 Lower screening among Hispanics was associated with disparities in CRC incidence and mortality among Hispanics in Florida, 32, 33 Puerto Rico, 34 and New Mexico. 35 In several states with large Hispanic populations, rates of CRC have declined faster among whites, who now have lower CRC incidence and mortality than Hispanic men. 36 Despite these similarities, California's Hispanic population differs from the rest of the U.S. in several ways: California has a larger proportion of Hispanics of Mexican descent, a higher proportion born outside the U.S., and a higher proportion speaking a language other than English at home. Tailoring interventions to the needs of these specific groups will be important in creating effective CRC prevention strategies. 24, 37 Factors other than screening may explain some of the disparities in mortality and incidence between white and Hispanic men. CRC is associated with several lifestyle factors, including alcohol consumption, smoking, diabetes, and obesity. [38] [39] [40] [41] Recent Hispanic immigrants are less likely to smoke and consume excessive alcohol and are more likely to have healthy dietary habits than U.S.-born Hispanics. 42 However, as Hispanics become more acculturated, they become less likely to maintain many aspects of a healthy lifestyle, which may offset any improvement from increased screening.
Limitations
This study has some limitations. Although the North American Association of Central Cancer Registries' algorithm to classify Hispanic ethnicity has been adopted by most cancer registries in the U.S., residual misclassification is a possibility. Misclassification has been reported for CRC as the underlying cause of death, although most of inaccuracies were due to death certificates assigning colon as the cause of death for rectal cancer patients, given the interchangeable use of the terms colon and colorectal. 14 In addition, screening quality may differ between whites and Hispanics, which could attenuate the preventive effect of polyp removal. Despite these limitations, the size and diversity of the California population and the quality of California Cancer Registry data are important factors in bringing to light the disparities uncovered in this study.
Conclusions
Although CRC incidence and mortality rates have remained relatively flat for Hispanic men in California, CRC incidence in 2012 was lower than in any year since 1990, following 3 consecutive years of decline. It remains to be seen if this trend continues, translating into lower mortality in the future. Rates of screening among Hispanic men in age groups where screening is recommended are also increasing, from 42% in 2003 to 59% in 2009. 43, 44 Despite these positive signs, more-effective strategies aimed at both Hispanics and their healthcare providers are needed to increase CRC screening among Hispanic men and reduce their CRC burden. 
